skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Winners of the Global Generics & Biosimilars Awards 2019 were announced at a gala ceremony on 5 November 2019 at the Frankfurt Marriott Hotel, Germany.

The Awards – which were presented by Generics Bulletin in association with IQVIA – honor the year’s most outstanding achievements across the global generics, biosimilars and value added medicines industries.

A panel of 16 distinguished judges chose from a shortlist of high-caliber nominees from around the globe.  The evening was presided over by Angela Lamont and saw over 300 generics and biosimilars professionals gather to celebrate the industry winners.

"Generics Bulletin and Informa Pharma Intelligence are delighted to congratulate the worthy winners of the 2019 Global Generics & Biosimilars Awards,” said Dave Wallace, Executive Editor of Generics Bulletin. “The winners, shortlisted candidates, and indeed all entries to the Awards, are great examples of the dedication and commitment that the generics, biosimilars and value-added medicines industries demonstrate every day in making more affordable treatments more accessible to ever more people around the world.”

Following is the complete list of this year’s Global Generics & Biosimilars Awards winners.


  • Company of the Year: Aurobindo
  • Company of the Year, Americas: Eurofarma
  • Company of the Year, Asia-Pacific: Beximco
  • Company of the Year, EMEA: Stada
  • API Supplier of the Year: Dr Reddy’s
  • Biosimilar Initiative of the Year: Shanghai Henlius Biotech
  • Acquisition of the Year: Aurobindo
  • Leader of the Year: Zentiva
  • Industry Partner of the Year: Rephine
  • Value Added Medicine Initiative of the Year: Accord
  • Business Development of the Year: PharmEvo
  • Regulatory Achievement of the Year: Sandoz
  • Legal Strategy of the Year: Accord
  • CRS Initiative of the Year: Teva

For sponsorship information on next year’s Global Generics & Biosimilars Awards, please contact Rob Coulson at Generics bulletin. Direct line: +44 (0)20 7017 4392 Mobile: +44 (0)7900 658185

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: